References
1. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Seow A, Lee HP
Population-based cancer survival in Singapore, 1968 to 1992: an overview.
Int J Cancer; 93(1):142-7 2001 [pubmed]
2. Ursin G, Bernstein L, Pike MC.
Breast cancer
Cancer Surv 1994;19-20:241-264 [pubmed]
3. Breast cancer. Facts and Figures
[BCI]
4. Rao DN, Ganesh B
Estimate of cancer incidence in India in 1991.
Indian J Cancer; 35(1):10-8 1998 [pubmed]
5. Sambhu Pal
Breast cancer in India.
6. Shukla NK, Seenu V, Goel AK, Raina V, Rath GK, Singh R, Kriplani AK, Deo SV, Misra MC
Male breast cancer: a retrospective study from a regional cancer center in northern India.
J Surg Oncol 1996 Feb;61(2):143-148 [pubmed]
7. Badwe RA, Gangawal S, Mittra I, Desai PB.
Clinico-pathological features and prognosis of breast cancer in different religious communities in India
Indian J Cancer 1990 Dec;27(4):220-228 [pubmed]
8. Jussawalla DJ, Yeole BB, Natekar MV.
Histological and epidemiological features of breast cancer in different religious groups in greater Bombay.
J Surg Oncol 1981;18(3):269-279 [pubmed]
9. Jussawalla DJ, Jain DK.
Breast cancer and religion in greater Bombay women: an epidemiological study of 2130 women over a 9-year period
Br J Cancer 1977 Nov;36(5):634-638 [pubmed]
10. Sharma RG, Ajmera R, Saxena O.
Cancer profile in eastern Rajasthan
Indian J Cancer 1994 Sep;31(3):160-173
[pubmed]
11. Hussain MA, Ali S, Tyagi SP, Reza H.
Incidence of cancer breast at Aligarh.
J Indian Med Assoc 1994 Sep;92(9):296-297 [pubmed]
12. Nandakumar A, Anantha N, Venugopal TC, Sankaranarayanan R, Thimmasetty K, Dhar M.
Survival in breast cancer: a population-based study in Bangalore, India
Int J Cancer 1995 Mar 3;60(5):593-596 [pubmed]
13. Kapoor R, Goswami KC, Kapoor B, Dubey VK.
Pattern of cancer in Jammu region (hospital based study 1978-'87).
Indian J Cancer 1993 Jun;30(2):67-71 [pubmed]
14. Gadhia PK, Panchal ND, Bhagwat SV.
Cancer profile in Surat and its vicinity.
J Indian Med Assoc; 93(3):101-2 1995 [pubmed]
15. Jussawalla DJ, Yeole BB, Natekar MV, Rajagopalan TR.
Cancer in the Sindhi population of Greater Bombay.
Cancer 1980 Nov 1;46(9):2107-2115 [pubmed]
16. Kulkarni PV, Jaiswal SS, Rathod SB, Khalique A, Kulkarni RR.
Profile of malignancies at Medical College, Ambajogai--(15 years retrospective study).
Indian J Cancer 1996 Mar;33(1):31-36 [pubmed]
17. Jussawalla DJ, Yeole BB, Natekar MV.
Cancer in Indian Moslems.
Cancer 1985 Mar 1;55(5):1149-1158 [pubmed]
18. Juneja A, Murthy NS, Sehgal A, Prabhakar AK, Luthra UK.
Risk for development of cancer in three urban areas of India
Neoplasma 1990;37(4):483-488 [pubmed]
19. Height linked to breast cancer risk.
Sept 2000. BBC News
20. Gajalakshmi CK, Shanta V, Hakama M
Risk factors for contralateral breast cancer in Chennai (Madras), India.
Int J Epidemiol; 27(5):743-50 1998 [pubmed]
21. Gajalakshmi CK, Shanta V, Hakama M
Survival from contralateral breast cancer.
Breast Cancer Res Treat; 58(2):115-22 1999 [pubmed]
22. Gajalakshmi CK, Shanta V
Risk factors for female breast cancer.A hospital-based case-control study in Madras,India.
Acta Oncol 1991;30(5):569-574 [pubmed]
23. Ray G, Husain SA
Role of lipids, lipoproteins and vitamins in women with breast cancer.
Clin Biochem ; 34(1):71-6 2001 [pubmed]
24. Rao DN, Ganesh B, Desai PB
Role of reproductive factors in breast cancer in a low-risk area: a case-control study.
Br J Cancer; 70(1):129-32 1994 [pubmed]
25. Bhatt RV
Environmental influence on reproductive health.
Int J Gynaecol Obstet; 70(1):69-75 2000 [pubmed]
26. Roy SK, Trivedi AH, Bakshi SR, Patel RK, Shukla PH, Patel SJ, Bhatavdekar JM, Patel DD, Shah PM
Spontaneous chromosomal instability in breast cancer families.
Cancer Genet Cytogenet; 118(1):52-6 2000 [pubmed]
27. Shevde LA, Rao NM, Joshi NN, Shinde SR, Ghosh SN, Nadkarni JJ
Natural killer cell function and genetic instability in unaffected individuals from breast cancer families.
Eur J Cancer Prev; 7(2):141-8 1998
[pubmed]
28. Jyothish B, Ankathil R, Chandini R, Vinodkumar B, Nayar GS, Roy DD, Madhavan J, Nair MK
DNA repair proficiency: a potential marker for identification of high risk members in breast cancer families.
Cancer Lett; 124(1):9-13 1998 [pubmed]
29. Karelia NH, Patel DD, Balar DB, Desai NS, Patel SU, Dave K, Shah GB
Prognostic significance of tumor angiogenesis in advanced breast carcinoma: an Indian experience.
Neoplasma; 44(3):163-6 1997 [pubmed]
30.Patel DD, Bhatavdekar JM, Chikhlikar PR,
Ghosh N, Suthar TP, Shah NG, Mehta RH, Balar DB
Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor
of
poor prognosis compared to newer and established prognosticators.
J Surg Oncol; 62(2):86-92 1996 [pubmed]
31. Rao NM, Joshi NN, Shinde SR, Advani SH, Ghosh SN
Premature separation of centromere and aneuploidy: an indicator of high risk in unaffected individuals
from familial
breast cancer families?
Eur J Cancer Prev; 5(5):343-50 1996
[pubmed]
32. Rao NM, Pai SA, Shinde SR, Ghosh SN
Reduced DNA repair capacity in breast cancer patients and unaffected individuals from breast cancer families.
Cancer Genet Cytogenet; 102(1):65-73 1998 [pubmed]
33. Trivedi AH, Roy SK, Bhachech SH, Patel RK, Dalal AA, Bhatavdekar JM, Patel DD
Cytogenetic evaluation of 20 sporadic breast cancer patients and their first degree relatives.
Breast Cancer Res
Treat; 48(2):187-90 1998 [pubmed]
34. Claus EB, Risch N, Thompson WD
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.
Cancer 1994 Feb 1;73(3):643-651 [pubmed]
35. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill
JJ.
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
J Natl Cancer
Inst
1989 Dec 20;81(24):1879-1886 [pubmed]
36. Briki F, Busson B, Salicru B, Esteve F, Doucet J.
Breast-cancer diagnosis using hair.
Nature 1999 Jul
15;400(6741):226
[pubmed]
37. James V, Kearsley J, Irving T, Amemiya Y, Cookson D.
Using hair to screen for breast cancer.
Nature 1999 Mar
4;398(6722):33-34
[pubmed]
38. Muthuswamy S, Raste AS.
Clinical significance of cancer antigen, CA 15.3 in breast cancer.
Indian J Med
Sci 2000 Oct;54(10):442-447
[pubmed]
39. Gion M, Mione R, Leon AE, Luftner D, Molina R, Possinger K, Robertson JF.
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases.
Eur J Cancer 2001 Feb;37(3):355-363
[pubmed]
40. Cianga C, Suliman I.
The reflection of the dynamics of the serum markers CA l5.3 and CEA in breast cancer
Rev Med Chir Soc Med Nat Iasi 1998 Jul;102(3-4):93-95
[pubmed]
41. Van Dalen A.
Analytical requirements and standardization of CA 15-3.
Scand J Clin Lab Invest Suppl 1995;221:102-104
[pubmed]
42. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA,
Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM,
Ding W, et al.
A strong candidate for the breast and ovarian cancer susceptibility
gene BRCA1
Science
1994 Oct 7;266(5182):66-71 [pubmed]
43. Wooster R, Bignell G, Lancaster J, Swift S, Seal
S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G.
Identification of the breast cancer susceptibility gene BRCA2.
Nature 1995 Dec 21;378(6559):789-792
[pubmed]
44. Boddy MN, Freemont PS, Borden KL.
The p53-associated protein MDM2 contains a newly characterized zinc-binding
domain called the RING finger.
Trends
Biochem Sci 1994 May;19(5):198-199 [pubmed]
45. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A,
Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R.
Identification of a RING protein that can interact in vivo with the
BRCA1 gene product
Nat
Genet 1996 Dec;14(4):430-440 [pubmed]
46. Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul
SF, Koonin EV
A superfamily of conserved domains in DNA damage-responsive cell cycle
checkpoint proteins.
FASEB J 1997
Jan;11(1):68-76 [pubmed]
47. Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao
J, Chen PL, Sharp ZD, Lee WH.
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA
damage response.
Science
1999 Jul 30;285(5428):747-750 [pubmed]
48. Pestonjamasp PH, Mittra I
Analysis of BRCA1 involvement in breast cancer in Indian women
J Biosci; 25(1):19-23 2000 [pubmed]
49. Easton DF, Ford D, Bishop DT.
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
Am J Hum Genet 1995 Jan;56(1):265-271 [pubmed]
50. Chen JJ, Silver D, Cantor S, Livingston DM, Scully
R.
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway
Cancer
Res 1999 Apr 1;59(7Suppl) [pubmed]
51. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada
A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein
DM, Bowcock Isselbacher KJ,
Haber DA.
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
N Engl J Med 1997 May 15;336(20):1416-1421
[pubmed]
52. Dobrovic A, Simpfendorfer D.
Methylation of the BRCA1 gene in sporadic breast cancer.
Cancer Res 1997 Aug 15;57(16):3347-50 [pubmed]
53. Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL.
p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
J Natl Cancer Inst 2001 May 2;93(9):700-704
[pubmed]
54. Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM.
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Oncogene 2001 Aug 2;20(34):4621-4628
[pubmed]
55. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA,
Mulligan LM, Mutter GL, Eng C.
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
Am J Pathol 1999 Oct;155(4):1253-1260
[pubmed]
56. Choi HS, Park YJ, Park JG.
Peutz-Jeghers syndrome: a new understanding.
J Korean Med Sci 1999 Feb;14(1):2-7
[pubmed]
57. Li S, Ting NS, Zhen L, Chen PL,
Ziv Y, Shiloh Y, Lee Y, Lee WH.
Functional
link of BRCA1 and ataxia telengectasia gene product in DNA damage
response.
Nature 2000 jul 13;406(6792):210-5
[pubmed]
58. Smart missiles torpedo cancer
59. Gene therapy 'prevents cancer'
60. Scientists crack cancer secret
62. NI cancer breakthrough hope
63. Breast cancer vaccine on trial
64. Lin J, Page C, Jin X, Sethi AO, Patel R, Nunez G.
Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
Anticancer Res 2001 Mar-Apr;21(2A):831-9 [pubmed]
65. Nayak BK, Das BR.
Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast
tumours
Mol Biol
Rep 1999 Dec;26(4):223-30 [pubmed]
66. Nayak BK, Das BR.
Mutation
and methylation status of p53 gene promoter in human breast tumours
Tumour Biol. 1999 Nov-Dec;20(6):341-6.[pubmed]
67. Nayak BK, Patnaik S, Das BR.
Rearrangement of the p53 gene in human breast
tumours.
Biochem Biophys Res Commun 1998 Apr 17;245(2):388-91 [pubmed]
68. Nayak BK, Das BR.
Differential binding of nuclear proteins to the TP53 gene
promoter in male breast tumour
Eur J Cancer 1997 Aug;33(9):1484-7 [pubmed]
69. Nayak BK, Baral RN, Das BR.
p53 gene mutation in relation to p53 protein accumulation in
male and female breast cancer
Neoplasma 1996;43(5):305-10 [pubmed]
70. Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam
G.
Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras
genes in Indian breast carcinomas
Int J Oncol 2000 Nov;17(5):1031-5 [pubmed]
71. Kachhap SK, Dange P, Nath Ghosh S.
Effect of omega-6 polyunsaturated fatty acid (linoleic acid) on
BRCA1 gene expression in MCF-7 cell line.
Cancer Lett 2000 Jun 30;154(2):115-20 [pubmed]
72. Kesari AL, Chellam VG, Nair PP, Ahmed I, Madhavan J, Thomas PA, Nair MK,
Pillai MR.
p53 tumor suppressor protein and tissue proliferative fraction
in infiltrating duct carcinoma
J Surg Oncol 1997 Jul;65(3):159-63 [pubmed]
73.Madhavan M, Srinivas P, Abraham E, Ahmed I, Mathew A, Vijayalekshmi NR,
Balaram P.
Cadherins as predictive markers of nodal metastasis in breast
cancer.
Mod Pathol 2001 May;14(5):423-7 [pubmed]
74.Ito Y, Gajalakshmi KC, Sasaki R, Suzuki K, Shanta V.
A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India
J Epidemiol 1999 Nov;9(5):306-14 [pubmed]
75.Singh V, Garg AN.
Trace element correlations in the blood of Indian women with breast cancer
Biol Trace Elem Res 1998 Summer;64(1-3):237-45 [pubmed]
77.Coumoul X, Diry M, Robillot C, Barouki R.
Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and
pesticides in the breast tumor
cell
line MCF-7.
Cancer Res 2001 May 15;61(10):3942-8 [pubmed]
78.Angus WG, Larsen MC, Jefcoate CR.
Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell
lines: role of
estrogen receptor status
Carcinogenesis 1999 Jun;20(6):947-55 [pubmed]
79.Millikan RC
NAT1*10 and NAT1*11 polymorphisms and breast cancer risk.
Cancer Epidemiol Biomarkers Prev 2000 Feb;9(2):217-9 [pubmed]
80.Gertig DM, Hankinson SE, Hough H, Spiegelman D, Colditz GA, Willett WC, Kelsey KT, Hunter DJ.
N-acetyl transferase 2 genotypes, meat intake and breast cancer risk.
Int J Cancer 1999 Jan 5;80(1):13-7 [pubmed]
81.Curran JE, Weinstein SR, Griffiths LR.
Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility.
Cancer Lett 2000 May 29;153(1-2):113-20 [pubmed]
82.Curran JE, Weinstein SR, Griffiths LR.
Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility.
Cancer Lett 2000 May 29;153(1-2):113-20 [pubmed]
83.Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D.
Glutathione S-transferases M1, T1, and P1 and breast cancer.
Cancer Epidemiol Biomarkers Prev 2000 Jun;9(6):567-73 [pubmed]
84.Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.
Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
Cancer Epidemiol Biomarkers Prev 2001 Mar;10(3):229-36 [pubmed]
85.Salinas AE, Wong MG.
Glutathione S-transferases - a review
Curr Med Chem 1999 Apr;6(4):279-309 [pubmed]
86.Maugard CM, Charrier J, Bignon YJ.
Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility.
Chem Biol Interact 1998 Apr 24;111-112:365-75 [pubmed]
87.Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE, Miller AB.
Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada).
Cancer Causes Control 2001 Jun;12(5):395-404 [pubmed]
88.Hoyer AP, Jorgensen T, Rank F, Grandjean P.
Organochlorine exposures influence on breast cancer risk and survival according to estrogen
receptor status: a Danish
cohort-nested
case-control study
BMC Cancer 2001;1(1):8 [pubmed]